Trulieve Announces New Medical Cannabis Store in Homosassa, Florida, with Grand Opening Event Scheduled for July 5th
PorAinvest
martes, 2 de julio de 2024, 8:02 am ET1 min de lectura
CSSE--
Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF), a leading cannabis company in the United States, has announced the opening of three new medical cannabis dispensaries in Florida. The latest additions to Trulieve's network of stores include Homosassa, Madison, and Panama City [1].
The Homosassa location, the first in the area, is expected to hold a grand opening event on July 5. The event will feature music, specials, and patient education sessions. Trulieve aims to provide local medical cannabis patients with a convenient, accessible, and comprehensive service.
Trulieve's expansion in Florida follows the recent approval of the #YesOn3 ballot initiative for adult use. The company has been actively increasing its presence in the state to cater to the growing demand for medical and recreational cannabis.
According to a report by Grand View Research, the global medical cannabis market is expected to reach $146.9 billion by 2027, growing at a compound annual growth rate (CAGR) of 30.1% during the forecast period [2]. In the United States, medical cannabis sales reached $6.7 billion in 2021 and are projected to reach $40 billion by 2027, growing at a CAGR of 30% [3].
Trulieve's new dispensaries in Homosassa, Madison, and Panama City will offer a wide variety of popular products, including the company's in-house brands such as Alchemy, Co2lors, Cultivar Collection, Modern Flower, Momenta, Muse, Roll One, Sweet Talk, and Trekkers. Customers will also have access to beloved partner brands like Alien Labs, Bellamy Brothers, Binske, Black Tuna, Blue River, Connected Cannabis, DeLisioso, Khalifa Kush, Love's Oven, Miami Mango, O.pen, Seed Junky, and Sunshine Cannabis [1].
In addition to the new stores, Trulieve offers home delivery, convenient online ordering, and in-store pickup. Veterans receive a 20% discount on every order, and all first-time guests are eligible for a 60% new customer discount [1].
Sources:
[1] Trulieve Press Release. (2024, July 1). Trulieve Opens Florida Medical Cannabis Dispensaries in Madison, Panama City, and Homosassa. Retrieved from https://finance.yahoo.com/news/trulieve-open-florida-medical-cannabis-120000799.html
[2] Grand View Research. (2021, May 3). Global Medical Cannabis Market Size, Share & Trends Analysis Report By Product Type, By Application, By End-User, By Region, And Segment Forecasts, 2021 - 2028. Retrieved from https://www.grandviewresearch.com/industry-analysis/medical-cannabis-market
[3] Statista. (2022, March 23). US medical cannabis market size 2021-2027. Retrieved from https://www.statista.com/statistics/1361734/us-medical-cannabis-market-size/
QQQX--
TRU--
Trulieve Cannabis Corp. will open a new medical cannabis dispensary in Homosassa, Florida, offering high-quality branded products and customer service. The facility will host a grand opening event on July 5th, featuring music, specials, and patient education sessions. The Homosassa location will be the first in the area, providing local medical cannabis patients with a convenient, accessible, and comprehensive service.
Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF), a leading cannabis company in the United States, has announced the opening of three new medical cannabis dispensaries in Florida. The latest additions to Trulieve's network of stores include Homosassa, Madison, and Panama City [1].
The Homosassa location, the first in the area, is expected to hold a grand opening event on July 5. The event will feature music, specials, and patient education sessions. Trulieve aims to provide local medical cannabis patients with a convenient, accessible, and comprehensive service.
Trulieve's expansion in Florida follows the recent approval of the #YesOn3 ballot initiative for adult use. The company has been actively increasing its presence in the state to cater to the growing demand for medical and recreational cannabis.
According to a report by Grand View Research, the global medical cannabis market is expected to reach $146.9 billion by 2027, growing at a compound annual growth rate (CAGR) of 30.1% during the forecast period [2]. In the United States, medical cannabis sales reached $6.7 billion in 2021 and are projected to reach $40 billion by 2027, growing at a CAGR of 30% [3].
Trulieve's new dispensaries in Homosassa, Madison, and Panama City will offer a wide variety of popular products, including the company's in-house brands such as Alchemy, Co2lors, Cultivar Collection, Modern Flower, Momenta, Muse, Roll One, Sweet Talk, and Trekkers. Customers will also have access to beloved partner brands like Alien Labs, Bellamy Brothers, Binske, Black Tuna, Blue River, Connected Cannabis, DeLisioso, Khalifa Kush, Love's Oven, Miami Mango, O.pen, Seed Junky, and Sunshine Cannabis [1].
In addition to the new stores, Trulieve offers home delivery, convenient online ordering, and in-store pickup. Veterans receive a 20% discount on every order, and all first-time guests are eligible for a 60% new customer discount [1].
Sources:
[1] Trulieve Press Release. (2024, July 1). Trulieve Opens Florida Medical Cannabis Dispensaries in Madison, Panama City, and Homosassa. Retrieved from https://finance.yahoo.com/news/trulieve-open-florida-medical-cannabis-120000799.html
[2] Grand View Research. (2021, May 3). Global Medical Cannabis Market Size, Share & Trends Analysis Report By Product Type, By Application, By End-User, By Region, And Segment Forecasts, 2021 - 2028. Retrieved from https://www.grandviewresearch.com/industry-analysis/medical-cannabis-market
[3] Statista. (2022, March 23). US medical cannabis market size 2021-2027. Retrieved from https://www.statista.com/statistics/1361734/us-medical-cannabis-market-size/

Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios